Centene (Centene) Interest Expense

: $-725 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Centene's interest expense for the three months ended in Dec. 2023 was $ -183 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-725 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Centene's Operating Income for the three months ended in Dec. 2023 was $ -143 Mil. Centene's Interest Expense for the three months ended in Dec. 2023 was $ -183 Mil. Centene did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Centene Interest Expense Historical Data

The historical data trend for Centene's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-412.00

-728.00

-665.00

-725.00

Centene Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense																-174.00	-180.00	-181.00	-181.00	-183.00

Centene Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-725 Mil.

Centene (NYSE:CNC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Centene's Interest Expense for the three months ended in Dec. 2023 was $-183 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-143 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $18,590 Mil.

Centene's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Centene did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Centene (Centene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

CNC:Mexico 1CNC:Italy QEN:Germany QEN:Germany C1NC34:Brazil

Address

7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105

Website

https://www.centene.com

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Executives

Lori Jean Robinson	director	5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher	officer: EVP, CFO	8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray	officer: EVP, Chief Transform. Officer	500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii	director	1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford	director	C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola	officer: EVP, Health Care Enterprises	500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley	officer: EVP, Chief Admin. Officer	7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt	director	822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin	director
H James Dallas	director	127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks	officer: SVP, Chief Information Officer	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas	officer: EVP, MARKETS	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk	director	C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A	officer: EVP, Mergers & Acquisitions	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105